Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wiik Pharma
Hinnerup, Denmark
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Wiik Pharma is a commercial radiopharmaceutical distributor that supplies nuclear medicine and PET departments across the Nordic region and acts as an exclusive regional distributor for products such as Telix’s prostate cancer imaging agent ILLUCCIX (gallium-68 gozetotide).
- Modalities
- RadiopharmaceuticalRadiopharmaceutical diagnostic agentRadiopharmaceutical therapeutic agent
- Industry
- Biotech
02
Partnerships
Telix Pharmaceuticals (exclusive distribution of Illuccix in Denmark, Finland, Norway and Sweden)
Beyond the preview
Go deeper on Wiik Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wiik Pharma.